radionuclide labeling process for somatostatin analogs associated with diseases whose pathophysiology involves somatostatin receptors, 'in vivo' and / or 'in vitro' diagnostic reagent based on radionuclide somatostatin analogues, 'in vitro' diagnostic methods and / or 'in vivo' of diseases whose pathophysiology involves somatostatin receptors using the reagent thus obtained and a kit for diagnosing diseases whose pathophysiology involves somatostatin receptors based on said reagent

摘要

MARKING PROCESS WITH SOMATOSTATIN ANALOGUE RADIONUCLIDS ASSOCIATED WITH DISEASES WHOSE PHYSIOPATHOGENY INVOLVES SOMATOSTATIN RECEPTORS, REAGENT FOR "IN VIVO" DIAGNOSIS AND BIO DIAGNOSIS AND / OR "IN VIVO" OF DISEASES WHICH PHYSIOPATHOGENIA INVOLVES SOMATOSTATIN RECEIVERS USING THE SO OBTAINED REAGENT AND DISEASE DIAGNOSTIC KIT WHOSE PHYSIOPATHOGENIA INVOLVES SOMATOSTATINE RECEIVERS. The present invention relates to a radionuclide labeling process for somatostatin analogs as well as to the in vivo or in vitro diagnostic reagent based on radionuclide labeled somatostatin analogues, their use for diagnosis, "in vitro" and "in vivo" diagnostic method for diseases whose pathophysiology involves somatostatin receptors and the diagnostic kit for these diseases using said reagent.